COMPARISON OF THE TREATMENT OUTCOMES OF CLOTRIMAZOLE 100MG AND CLOTRIMAZOLE 500MG REGIMENS FOR FUNGAL VAGINITIS IN GRAVID WOMEN: A CONTROLLED INTERVENTIONAL STUDY
Main Article Content
Abstract
Background: A single-dose vaginal tablet regimen of Clotrimazole 500mg has been shown to improve patient compliance and effectively treat fungal vaginitis. However, few studies have directly compared its efficacy with the Clotrimazole 100mg regimen. Objective: To compare the treatment outcomes of fungal vaginitis using Clotrimazole 500mg and 100mg regimens. Materials and methods: A controlled interventional study was conducted on 44 gravid woman diagnosed with fungal vaginitis at Binh Duong Provincial General Hospital. Patients were divided into two groups: Clotrimazole 500mg (n=25) and Clotrimazole 100mg (n=19). Results: The mean age of the patients was 28.6 ± 7.6 years, with 75.0% having at least one child and 72.7% regularly sun-drying their underwear. Among them, 25% had a history of fungal vaginitis, 13.6% had used antibiotics, 11.4% had diabetes, 11.4% practiced vaginal douching, and 11.4% wore tight clothing. There were no statistically significant differences between the two groups regarding these characteristics (p>0.05). At the two-week follow-up, the proportion of patients with negative wet mount microscopy was higher in the Clotrimazole 500mg group than in the 100mg group (88.0% vs. 26.3%, p<0.001). The cure rate after two weeks was also higher in the Clotrimazole 500mg group compared to the 100mg group (88.0% vs. 26.3%, p<0.001). Conclusion: The Clotrimazole 500mg regimen demonstrated superior efficacy in treating fungal vaginitis compared to the Clotrimazole 100mg regimen.
Article Details
Keywords
fungal vaginitis, Clotrimazole 500mg regimen, Clotrimazole 100mg regimen
References


2. Loendersloot E. W., Goormans E., Wiesenhaan P. E., Barthel P. J., Branolte J. H. Efficacy and tolerability of single-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of Clotrimazole. American Journal of Obstetrics and Gynecology. 1985. 152(7, Part 2), 953-955. doi:https://doi.org/10.1016/S0002-9378(85)80008-9.


3. Phạm Hùng Cường, Nguyễn Thạc Văn, Bùi Chí Thương. Tỷ lệ thành công của phác đồ Clotrimazole liều duy nhất trong điều trị viêm âm đạo do nấm trong thai kỳ tại bệnh viện phụ sản MêKông. Tạp chí Y học Việt Nam. 2024. 538(3), 375-380. doi:https://doi.org/10.51298/vmj. v538i3.9653.


4. Trần Thị Thúy, Phạm Phương Lan, Dương Lan Dung, Nguyễn Thị Ngọc Mai, Nguyễn Văn Liệp. Đặc điểm lâm sàng, cận lâm sàng và thực hành ở thai phụ viêm âm đạo và công tác chăm sóc, tư vấn tại Bệnh viện Phụ sản Trung ương năm 2022. Tạp chí Y học Dự phòng. 2023. 33(3 Phụ bản), 170-178. doi:https://doi.org/ 10.51403/0868-2836/2023/1167.


5. Sobel J. D. Vulvovaginal candidosis. Lancet. 2007. 369(9577), 1961-71. doi:10.1016/s0140-6736(07)60917-9.


6. Lê Chí Công, Phạm Văn Lình, Dương Mỹ Linh. Tình hình, đặc điểm lâm sàng, cận lâm sàng của viêm âm đạo ở thai phụ 3 tháng cuối thai kỳ tại bệnh viện phụ sản thành phố Cần Thơ. Tạp chí Y Dược học Cần Thơ. 2020. (28), 37-44.

7. Akah PA, Nnamani CE, Nnamani PO. Prevalence and treatment outcome of vulvovaginal candidiasis in pregnancy in a rural community in Enugu State, Nigeria. Journal of Medicine and Medical Sciences.2010.1(10),448 - 452.

8. Young G. L., Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001. (4), Cd000225. doi:10.1002/14651858.Cd000225.

